Left ventricular assist devices: An ethical analysis |
| |
Authors: | Katrina A Bramstedt |
| |
Institution: | (1) University of California-Los Angeles, USA |
| |
Abstract: | United States statistics continue to indicate that the human donor heart pool does not and will not meet the great demand
for hearts. For those patients unresponsive to maximal medical therapy (approximately 60,000 patients per year), cardiac transplantation
is currently their best hope for increased survival. To address the need for additional end-stage congestive heart failure
(CHF) therapy options, three medical device manufacturers have developed implantable left ventricular assist devices (LVAD)
which act as a pump for hemodynamic support of the patient’s diseased heart. Although LVADs have been shown to improve patient
disease state prior to organ transplantation. LVADs do nothing to increase the pool of human donor hearts, and they negatively
impact the United Network for Organ Sharing (UNOS) waiting list by increasing the size of the waiting pool. This paper identifies
and explores the ethical challenges presented by the use of LVADs as a bridging technology for heart transplant candidates.
Although LVADs raise some ethical concerns, these concerns are outweighed by the proven medical efficacy of these devices.
Thus, this technology should continue to be used and further developed.
This paper was written by the author while in the Masters degree progrm at Loma Linda University (Dept. of Biomedical and
Clinical Ethics), 11234 Anderson Street, Coleman Pavillion, Loma Linda, CA 92354, USA.
The author is currently an Ethies Fellow (pre-doctoral) in UCLA’s program in Biomedical and Research Ethics. |
| |
Keywords: | ventricular assist device ethics transplantation |
本文献已被 PubMed SpringerLink 等数据库收录! |
|